Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist.
Wnorowski A, Dudzik D, Bernier M, Wójcik J, Keijzers G, Diaz-Ruiz A, Mazur K, Zhang Y, Han H, Scheibye-Knudsen M, Jozwiak K, Barbas C, Wainer IW.
Wnorowski A, et al. Among authors: jozwiak k.
Sci Rep. 2022 Mar 7;12(1):3618. doi: 10.1038/s41598-022-07600-x.
Sci Rep. 2022.
PMID: 35256673
Free PMC article.